Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia

BACKGROUND: Renal cell carcinoma (RCC) is a seventh ranked malignancy with poor prognosis. RCC is lethal at metastatic stage as it does not respond to conventional systemic treatments, and there is an urgent need to find out promising novel biomarkers for effective treatment. The goal of this study...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Cancer
Prif Awduron: Karim, Sajjad, Al-Maghrabi, Jaudah A., Farsi, Hasan M. A., Al-Sayyad, Ahmad J., Schulten, Hans-Juergen, Buhmeida, Abdelbaset, Mirza, Zeenat, Al-boogmi, Alaa A., Ashgan, Fai T., Shabaad, Manal M., NourEldin, Hend F., Al-Ghamdi, Khalid B. M., Abuzenadah, Adel, Chaudhary, Adeel G. A., Al-Qahtani, Mohammed H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2016
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5073805/
https://ncbi.nlm.nih.gov/pubmed/27766950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2775-2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg